Silintan 25-count pills recalled for undeclared meloxicam
SILINTAN 25 pills, sold in 25-count bottles, contain an undeclared ingredient called meloxicam, a prescription pain reliever. The FDA found this ingredient was not listed on the label and the product was not approved by the FDA. The recall affects all lots currently in use.
From the FDA notice · Read the official notice ↗
What to do
- Stop taking SILINTAN 25 pills immediately
- Do not use any remaining pills from the bottle
- Contact your doctor or pharmacist if you have taken this product and need guidance
- Consult a healthcare provider before starting any replacement product
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- N/A
- Illnesses reported
- None reported
- Manufactured in
- 7214 Berne St, N/A, Rosemead, CA, United States
- Classification
- Class I
- Recall number
- D-0388-2026
In the FDA's words
- Description
- SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam. All lots within expiry Distribution: USA nationwide Affected quantity: N/A
- Hazard
- Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.